67
5
23
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T4391 | Syk Inhibitor II dihydrochloride | Syk Inhibitor II (hydrochloride) | Others , Tyrosine Kinases , Syk , PKC , BTK |
Spleen tyrosine kinase (Syk) is a non-receptor tyrosine kinase that, upon phosphorylation, binds to immunoreceptor tyrosine-based activation motifs of FcRγ chains and mediates downstream signaling related to platelet fun... | |||
T13045 | Syk-IN-3 | Syk | |
Syk-IN-3 is a Syk inhibitor with potential anti-inflammatory and anticancer activity and can be used to study immune dysregulation. | |||
T4348 | Syk Inhibitor II | 5-HT Receptor , Syk | |
Syk inhibitor II, a cell-permeable, ATP-competitive, pyrimidine-carboxamide compound, selectively and reversibly inhibits Syk (IC50 = 41 nM). | |||
T9543 | Syk Inhibitor II hydrochloride | Others | |
The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of... | |||
T24843 | Syk-IN-1 | SykIN11,Syk-IN-11,Syk IN 11,Syk inhibitor-11,Syk inhibitor 11,Syk-inhibitor-11 | |
Syk-IN-11 is a selective Syk inhibitor. | |||
T37077 | Syk-IN-4 | ||
Syk-IN-4 is a potent, selective, and orally bioavailable inhibitor of SYK, demonstrating an IC50 of 0.31 nM. It targets SYK, which has been identified as a potential therapeutic target for autoimmunity and hematological ... | |||
T4263 | BAY 61-3606 | Syk inhibitor IV | Apoptosis , Syk |
BAY 61-3606 (Syk inhibitor IV) is a potent, ATP-competitive, reversible, and highly selective inhibitor of Syk tyrosine kinase activity (Ki= 7.5 nM), exhibiting no inhibitory effect against Btk, Fyn, Itk, Lyn, and Src. | |||
T40976 | Syk Kinase Peptide Substrate | ||
Syk Kinase Peptide Substrate is a Syk kinase peptide substrate. | |||
T70931 | SYK-IN-II | ||
SYK-IN-II is an inhibitor of the spleen tyrosine kinase (STK). | |||
T62691 | Syk Inhibitor II dihydrochloride dihydrate | ||
Syk Inhibitor II dihydrochloride dihydrate is a highly selective, potent, ATP-competitive Syk inhibitor (IC50: 41 nM). Syk Inhibitor II dihydrochloride dihydrate exhibits anti-allergic effects. | |||
T78943 | Syk-IN-7 | Syk | |
Syk-IN-7 (compound 17) acts as an inhibitor of spleen tyrosine kinase (SYK) [1]. | |||
T70930 | GSK SYK inhibitor | ||
The immunoregulator spleen tyrosine kinase (SYK) is upregulated in cutaneous lupus erythematosus (CLE). This double-blind, multicentre, Phase Ib study evaluated the safety, tolerability, pharmacokinetics, pharmacodynamic... | |||
T79443 | Syk-IN-8 | Syk | |
Syk-IN-8 (compound 19q) functions as a Syk inhibitor with demonstrated antiproliferative effects on a variety of hematological tumor cells. It specifically inhibits PLCγ2 phosphorylation and is applicable for blood cance... | |||
T63086 | SYK/JAK-IN-1 | ||
SYK/JAK-IN-1 is a dual SYK/JAK inhibitor with IC50 values of less than 5 nM for both SYK and JAK2. | |||
T28281 | OXSI-2 | OXSI 2,Syk Inhibitor | Syk |
OXSI-2 (Syk Inhibitor) is an inhibitor of Syk with an EC50 of 313 nM and an IC50 of 14 nM. OXSI-2 completely inhibits Adaptor protein LAT Y191 phosphorylation and Syk mediated events in platelets. | |||
T76083 | Syk Kinase Peptide Substrate, Biotin labeled | ||
The compound, Biotin-labeled Syk Kinase Peptide Substrate, is a peptide substrate of Syk kinase that is labeled with biotin. | |||
T16776 | RO9021 | Syk | |
RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM). | |||
T39437 | Cevidoplenib dimesylate | Syk | |
Cevidoplenib dimesylate is an inhibitor of spleen tyrosine kinase (Syk), possessing anti-inflammatory and immunomodulating properties. | |||
T11824LL | Lanraplenib | GS-9876 | Syk |
Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI ... | |||
T6101 | Entospletinib | GS-9973 | Syk |
Entospletinib (GS-9973) (IC50= 7.7 nM)is a specific Syk inhibitor, which is orally bioavailable. | |||
T14331 | Gusacitinib | ASN-002 | JAK , Syk |
Gusacitinib (ASN-002) (ASN-002) is spleen tyrosine kinase (SYK) and janus kinase (JAK) inhibitor (IC50: 5-46 nM). | |||
T6594 | MNS | Syk , Src , p97 | |
MNS is a tyrosine kinases inhibitor, inhibits Syk, Src, p97 with IC50 of 2.5 μM, 29.3 μM and 1.7 μM, respectively. | |||
T6115 | Fostamatinib | R788 | FLT , Syk , Monoamine Transporter , Adenosine Receptor |
Fostamatinib (R788)(IC50 of 41 nM), which is a prodrug of the active metabolite R406, is a Syk inhibitor. It does not work on Lyn. | |||
T3185 | R112 | (E)-Elafibranor | Syk |
R112 ((E)-Elafibranor) is an ATP-competitive inhibitor of Syk kinase. | |||
T2487 | Cerdulatinib | PRT2070,PRT062070 | Tyrosine Kinases , JAK , Syk |
Cerdulatinib (PRT2070) is an novel oral dual Syk/JAK inhibitor. | |||
T6174 | R406 | R-406 besylate | Apoptosis , FLT , Syk |
R406 (R-406 besylate) is an effective Syk inhibitor (IC50: 41 nM) and shows no effects on Lyn. | |||
T70929 | Naldemedine tosylate | S-297995 tosylate | |
Naldemedine tosylate (S-297995) is an orally active μ-opioid receptor antagonist (PAMORA) with high binding affinities (K_i = 0.34, 0.43, 0.94 nM) and potent antagonist activities (IC_50 = 25.57, 7.09, 16.1 nM) towards h... | |||
T6957 | PRT-060318 | P142-76,PRT318,PRT-060318 2HCl | Syk |
PRT-060318 (P142-76) is a novel selective inhibitor of the Syk tyrosine kinase, as an approach to HIT treatment. | |||
T6776 | BAY 61-3606 dihydrochloride | BAY 61-3606,BAY-61-3606 dihydrochloride | Apoptosis , Syk |
BAY 61-3606 dihydrochloride (BAY 61-3606) is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM). | |||
T2467 | R406 free base | R406 (free base) | Apoptosis , FLT , Syk |
R406 free base (R406 (free base)) is a potent Syk inhibitor. | |||
T0948 | Adrenalone hydrochloride | Adrenalone HCl | Adrenergic Receptor |
Adrenalone hydrochloride (Adrenalone HCl) is a dopamine β-oxidase inhibitor with a similar structure to the norepinephrine transporter (NET) ligand, with an IC50 of 36.9 μM. It is an adrenergic agonist that acts as a loc... | |||
T2696 | PRT062607 hydrochloride | PRT062607 (P505-15, BIIB057) HCl,P505-15 Hydrochloride | MLK , Syk , Src |
PRT062607 hydrochloride (P505-15 Hydrochloride) is a selective inhibitor of Syk (IC50: 1 nM). It displays at least 80-fold selectivity for Syk over other kinases. | |||
T4209 | TAK-659 hydrochloride | TAK-659 | VEGFR , FLT , Tyrosine Kinases , JAK , Syk |
TAK-659 hydrochloride (TAK-659) is a potent and selective inhibitor of spleen tyrosine kinase (SYK) with an IC50 value of 3.2 nM. It is selective against most other kinases, but potent toward both SYK and FLT3. | |||
T2605 | Fostamatinib Disodium | Tamatinib Fosdium,R788(Disodium),R788 Disodium,R788 (Fostamatinib) Disodium | FLT , Syk |
Fostamatinib Disodium (R788 Disodium) is an orally available Syk kinase inhibitor with potential anti-inflammatory and immunomodulating activities. | |||
T6104 | Cerdulatinib hydrochloride | Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride | MLK , c-Fms , Tyrosine Kinases , Hippo pathway , JAK , Syk |
Cerdulatinib hydrochloride (PRT2070 hydrochloride) is an oral active, multi-targeted tyrosine kinase inhibitor with IC50 of 12 nM/6 nM/8 nM/0.5 nM and 32 nM for JAK1/JAK2/JAK3/TYK2 and Syk, respectively. Also inhibits 19... | |||
T32088 | Sovleplenib | HMPL 523,HMPL523,HMPL-523 | Syk |
Sovleplenib (HMPL523) is an orally available, selective and potent inhibitor of the splenic tyrosine kinase SYK with an IC50 of 25 nM.Sovleplenib has antitumor activity and may be used in studies of immune thrombocytopen... | |||
T22430 | SRX3207 | Others , PI3K , Syk | |
SRX3207 is an inhibitor of Syk and PI3K and relieves tumor immunosuppression. | |||
T9789 | Cevidoplenib dimesylate hydrochloride | Syk | |
Cevidoplenib dimesylate hydrochloride is a spleen tyrosine kinase (Syk) inhibitor showing potential immunomodulating and anti-inflammatory properties. | |||
T2600 | AG490 | Zinc02557947,Tyrphostin AG 490,AG 490,AG-490,Tyrphostin B42 | EGFR , JAK , STAT , Autophagy |
AG490 (Tyrphostin B42) is an inhibitor of EGFR (IC50: 0.1 μM). It is 135-fold more selective for EGFR than ErbB2, also inhibits JAK2 with no effect to Lyn, Lck, Syk, Btk, and Src. | |||
T5524 | Aurora kinase inhibitor-3 | Aurora Kinase Inhibitor III | Aurora Kinase |
Aurora kinase inhibitor-3 (Aurora Kinase Inhibitor III) is a potent inhibitor of Aurora A kinase (IC50 = 42 nM).1 It is selective for Aurora A over BMX, BTK, IGF-1R, c-Src, TRKB, SYK, and EGFR. | |||
T2045 | JANEX-1 | Jak3 inhibitor I,WHI-P131 | JAK |
JANEX-1 (Jak3 inhibitor I) is a cell-permeable, reversible, effective, ATP-competitive, and selective inhibitor of JAK3 (IC50: 78 μM); little inhibitory against JAK1/2, or Zap/Syk or SRC tyrosine kinases. | |||
T6277 | Doramapimod | BIRB 796 | Raf , p38 MAPK , Autophagy |
Doramapimod (BIRB 796) is a highly potent inhibitor of p38 MAPK (Kd: 0.1 nM), but weakly inhibits c-RAF, Fyn, Lck, ERK-1, SYK, IKK2, and ZAP-70. | |||
T32613 | LCB 03-0110 dihydrochloride | Src | |
LCB 03-0110 Dihydrochloride is a potent inhibitor of the c-Src kinase (IC50 = 1.3 nM) and tyrosine kinases in the BTK and SYK family, as well as in the DDR2 family. It inhibits LPS-induced activation of macrophages and T... | |||
T9428 | HM43239 | FLT | |
HM43239 is an orally active and selective FLT3 inhibitor with IC 50 s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively. HM43239 directly inhibits the k... | |||
T3211 | Midostaurin | N-Benzoylstaurosporine,PKC412,CGP41231,CGP 41251 | Others , PKC |
PKC412(Midostaurin (PKC412); CGP41231; CGP41251) is a broad spectrum protein kinase inhibitor. Midostaurin inhibits protein kinase C alpha (PKCalpha), vascular endothelial growth factor receptor 2 (VEGFR2), c-kit, platel... | |||
T11824L | Lanraplenib monosuccinate | GS-9876 monosuccinate | Syk |
Lanraplenib monosuccinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib monosuccinate is a highly selective and orally... | |||
T24584 | P505-15 Acetate | PRT 062607 Acetate,P505 15 Acetate,PRT-062607 Acetate,PRT062607 Acetate,P50515 Acetate | Tyrosinase |
P505-15 Acetate is a selective inhibitor of spleen tyrosine kinase that acts by suppressing leukocyte immune function and inflammation and leading to a reduction in arthritis score and attenuated histological damage. | |||
T11824 | Lanraplenib succinate | GS-9876 succinate | Syk |
Lanraplenib succinate inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans. Lanraplenib succinate is a highly selective and orally active S... | |||
T21062 | TAK-659 | TAK 659,TAK659 | |
TAK-659 is a spleen tyrosine kinase (SYK) inhibitor. | |||
T16995 | TAS05567 | FLT , c-RET , JAK , Syk | |
TAS05567 is a potent, highly selective, and ATP-competitive Syk inhibitor (IC50: 0.37 nM). TAS05567 only shows >70% inhibition of Syk and 4 other kinases (FLT3, JAK2, KDR, and RET with IC50s of 10 nM, 4.8 nM, 600 nM, and... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN1644 | Flavanomarein | Others | |
Flavanomarein demonstrates potent antioxidative property, including free radical scavenging activity, inhibition of lipid peroxidation, as well as lipid-lowering effects in human HepG2 hepatocellular carcinoma cells trea... | |||
T0610 | Piceatannol | trans-Piceatannol,Astringenin | Apoptosis , Serine/threonin kinase , PKA , Syk , PKC , Autophagy |
Piceatannol (Astringenin) is an anti-inflammatory, immunomodulatory and antiproliferative agent. It inhibits p56lck and syk protein tyrosine kinases and inhibits NF-κB activation and gene expression of TNF-induced. It is... | |||
TN7075 | Linocinnamarin | 3-[4-(beta-D-Glucopyranosyloxy)phenyl]acrylic acid methyl ester | Phospholipase , Syk |
Linocinnamarin (3-[4-(beta-D-Glucopyranosyloxy)phenyl]acrylic acid methyl ester) is isolated from Fragaria ananassa Duch. (strawberry). The inhibition of antigen-stimulated degranulation by LN is mainly due to inactivati... | |||
T4S0498 | Glaucocalyxin A | Wangzaozin B,Leukamenin F | Apoptosis , Akt , Caspase , PI3K |
1. Glaucocalyxin A (Leukamenin F)-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery. 2. Glaucocalyxin A activates caspase-3, decreases BAD phosphorylation, and reduces the expressi... | |||
TN6667 | Spinacetin | ||
Spinacetin has anti-inflammatory effects, it weakly inhibited nitric oxide production and reduced prostaglandin E2 levels to different extents. It shows the activities in preventing inflammatory processes, which might be... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-00586 | CLEC-2 Protein, Mouse, Recombinant (hFc) | Mouse | HEK293 |
CLEC1B, also known as CLEC2, is a C-type lectin-like receptor expressed in myeloid cells and NK cells. Natural killer (NK) cells express multiple calcium-dependent (C-type) lectin-like receptors, such as CD94 and NKG2D, ... | |||
TMPY-03623 | NKp80/KLRF1 Protein, Cynomolgus, Recombinant (hFc) | Cynomolgus | HEK293 |
NKp80, also known as KLRF1, is an activating homodimeric C-type lectin-like receptor that is expressed on nearly all-natural killer cells and stimulates their cytotoxicity and cytokine release. NKp80 stimulates cytotoxic... | |||
TMPH-00544 | Epstein-Barr virus (strain B95-8) LMP2 Protein (His & SUMO) | EBV | E. coli |
Isoform LMP2A maintains EBV latent infection of B-lymphocyte, by preventing lytic reactivation of the virus in response to surface immunoglobulin (sIg) cross-linking. Acts like a dominant negative inhibitor of the sIg-as... | |||
TMPH-00323 | Snaclec rhodocytin subunit beta Protein, Calloselasma rhodostoma, Recombinant (His & Myc) | Calloselasma rhodostoma | E. coli |
Elicits platelet aggregation by the binding to the C-type lectin domain family 1 member B (CLEC1B/CLEC2). Binding leads to tyrosine phosphorylation in the cytoplasmic tail of CLEC1B, which promotes the binding of spleen ... | |||
TMPH-02441 | IL-15 Protein, Rhesus macaque, Recombinant (His) | Rhesus | Yeast |
Cytokine that stimulates the proliferation of T-lymphocytes. Stimulation by IL15 requires interaction of IL15 with components of the IL2 receptor, including IL2RB and probably IL2RG but not IL2RA. In neutrophils, stimula... | |||
TMPH-00320 | Snaclec rhodocytin subunit alpha Protein, Calloselasma rhodostoma, Recombinant (His) | Calloselasma rhodostoma | Yeast |
Elicits platelet aggregation by the binding to the C-type lectin domain family 1 member B (CLEC1B/CLEC2). Binding leads to tyrosine phosphorylation in the cytoplasmic tail of CLEC1B, which promotes the binding of spleen ... | |||
TMPH-00322 | Snaclec rhodocytin subunit beta Protein, Calloselasma rhodostoma, Recombinant (His) | Calloselasma rhodostoma | Yeast |
Elicits platelet aggregation by the binding to the C-type lectin domain family 1 member B (CLEC1B/CLEC2). Binding leads to tyrosine phosphorylation in the cytoplasmic tail of CLEC1B, which promotes the binding of spleen ... | |||
TMPJ-00252 | SIRP beta 1 Protein, Human, Recombinant (His) | Human | Human Cells |
Signal-regulatory protein beta-1 (SIRPB1, CD172b) is a member of the signal-regulatory-protein (SIRP) family, and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glyco... | |||
TMPH-00321 | Snaclec rhodocytin subunit alpha Protein, Calloselasma rhodostoma, Recombinant (His & SUMO) | Calloselasma rhodostoma | E. coli |
Elicits platelet aggregation by the binding to the C-type lectin domain family 1 member B (CLEC1B/CLEC2). Binding leads to tyrosine phosphorylation in the cytoplasmic tail of CLEC1B, which promotes the binding of spleen ... | |||
TMPY-02131 | Acid Phosphatase/ACP1 Protein, Human, Recombinant (GST) | Human | E. coli |
The low molecular weight phosphotyrosine phosphatase (LMW-PTP), also known as Acid phosphatase 1 (ACP1), belongs to the low molecular weight phosphotyrosine protein phosphatase family are involved in the regulation of im... | |||
TMPK-00252 | SIRP beta 1 Protein, Human, Recombinant (His & Avi) | Human | HEK293 |
SIRP beta 1 is a type I transmembrane protein belonging to the SIRP family within the Ig superfamily. Members of this family are characterized by an extracellular region containing a V-set Ig domain containing a J-like s... | |||
TMPK-00253 | SIRP beta 1 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 |
SIRP beta 1 is a type I transmembrane protein belonging to the SIRP family within the Ig superfamily. Members of this family are characterized by an extracellular region containing a V-set Ig domain containing a J-like s... | |||
TMPY-03440 | Sts1 Protein, Human, Recombinant (His) | Human | E. coli |
UBASH3B contains a ubiquitin associated domain at the N-terminus, an SH3 domain, and a C-terminal domain with similarities to the catalytic motif of phosphoglycerate mutase. UBASH3B was found to inhibit endocytosis of ep... | |||
TMPH-01342 | Filamin-A Protein, Human, Recombinant (His & Myc) | Human | E. coli |
Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplas... | |||
TMPY-02357 | CLEC-2 Protein, Human, Recombinant (His) | Human | HEK293 |
CLEC1B, also known as CLEC2, is a C-type lectin-like receptor expressed in myeloid cells and NK cells. Natural killer (NK) cells express multiple calcium-dependent (C-type) lectin-like receptors, such as CD94 and NKG2D, ... | |||
TMPJ-00534 | HFcgR4 Protein, Mouse, Recombinant (His) | Mouse | Human Cells |
Fcgr4, also known as CD16-2, is one of the receptors for Fc region of IgG which involve in immune responses. Fcgr4 mainly functions in cellular response to lipopolysaccharide, NK T cell proliferation, regulation of senso... | |||
TMPY-03173 | Dectin-2 Protein, Human, Recombinant (hFc) | Human | HEK293 |
C-type lectin domain family 4 member N (CLEC4N), also known as Dectin-2, is a C-type lectin expressed by dendritic cells (DCs) and macrophages. Members of the C-type lectin domain (CTLD) superfamily are metazoan proteins... | |||
TMPY-01202 | Dectin-2 Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
C-type lectin domain family 4 member N (CLEC4N), also known as Dectin-2, is a C-type lectin expressed by dendritic cells (DCs) and macrophages. Members of the C-type lectin domain (CTLD) superfamily are metazoan proteins... | |||
TMPH-01044 | CEACAM1 Protein, Human, Recombinant (His & Myc & SUMO) | Human | E. coli |
Cell adhesion protein that mediates homophilic cell adhesion in a calcium-independent manner. Plays a role as coinhibitory receptor in immune response, insulin action and functions also as an activator during angiogenesi... | |||
TMPH-01045 | CEACAM1 Protein, Human, Recombinant | Human | E. coli |
Cell adhesion protein that mediates homophilic cell adhesion in a calcium-independent manner. Plays a role as coinhibitory receptor in immune response, insulin action and functions also as an activator during angiogenesi... | |||
TMPH-01692 | MAPK3 Protein, Human, Recombinant (His) | Human | E. coli |
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate... | |||
TMPH-00297 | S100A9 Protein, Bovine, Recombinant (His & Myc & SUMO) | Bovine | E. coli |
S100A9 is a calcium- and zinc-binding protein which plays a prominent role in the regulation of inflammatory processes and immune response. It can induce neutrophil chemotaxis, adhesion, can increase the bactericidal act... | |||
TMPH-02962 | Lyn Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli |
Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors an... |